Back to Search
Start Over
KT‐413, A NOVEL IRAKIMID DEGRADER OF IRAK4 AND IMID SUBSTRATES, HAS A DIFFERENTIATED MOA THAT LEADS TO SINGLE‐AGENT AND COMBINATION REGRESSIONS IN MYD88 MT LYMPHOMA MODELS
- Source :
- Hematological Oncology. 39
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
Details
- ISSN :
- 10991069 and 02780232
- Volume :
- 39
- Database :
- OpenAIRE
- Journal :
- Hematological Oncology
- Accession number :
- edsair.doi...........553f512823d94e7a294acb42e6658290
- Full Text :
- https://doi.org/10.1002/hon.13_2879